Emergent BioSolutions Receives Approval for Large-Scale Manufacturing of BioThrax Pharmaceutical Investing
Medtronic Receives IDE Approval to Initiate Study for End-Stage Renal Disease Pharmaceutical Investing
Pediapharm Announces the Commercial Launch of Rupall(TM) (Rupatadine) in Canada Pharmaceutical Investing
Cellectar Biosciences Announces Additional US Patent Granted for CLR 131 and CLR 125 in a Broad Range of Solid Tumors Pharmaceutical Investing
Organovo Collaborates With Professor Melissa Little for Kidney Tissue Research Emerging Technology Investing
Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA Pharmaceutical Investing
Bioblast Announces Phase 2a Results of Trehalose in Patients with Spinocerebellar Ataxia Type 3 (SCA3) Pharmaceutical Investing
Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease Pharmaceutical Investing
